Middle/Senior Java Developer (Fibra)
Ajax Therapeutics
This listing was originally posted on Ajax Therapeutics's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAjax Systems, an international tech company and the largest manufacturer of security systems in Europe.
The System Division is responsible for building and developing the Ajax software ecosystem. The team develops and maintains OS Malevich and the Video Management System, builds scalable cloud infrastructure, and creates client applications for multiple platforms, ensuring that all system components work together as a unified ecosystem.
The division works with Java, Kotlin, Swift, C, C++, and Python. It includes embedded, cloud, mobile, and desktop engineers who ensure the stable operation of Ajax as a single digital platform.
We are looking for a Java developer to join the Fibra team, which is responsible for software support of hardware keys. The team develops and maintains server-side solutions to enable new hardware functionality for end users.
Ajax Systems is a Ukrainian success story that has grown into a global product. Ajax devices are trusted by more than 4.5 million end users and 330,000 PRO users in over 180 countries. The company provides comprehensive solutions to protect residential and commercial properties of all sizes. Today, Ajax portfolio includes 280 devices for intrusion protection, video surveillance, fire safety, and comfort and automation.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Ajax Therapeutics?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Computational chemistry and structural biology
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo